Editor's Note An experimental vaccine designed by researchers at University of Southern California has been shown to prevent serious infections from drug-resistant pathogens, according to an October 2023 study published by Science Translational Medicine. In this study, titled "A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogens," the…

Read More

Editor's Note The Food and Drug Administration (FDA), on September 11, approved the Moderna and Pfizer/BioNTech updated COVID-19 boosters that target the Omicron subvariant XBB.1.5, the September 11 Reuters reports. The boosters, which were approved for those 12 years and older and authorized for emergency use for children ages 6…

Read More

Editor's Note The COVID-19 hospital admission rate in the US rose some 16% to more than 17,400 for the week ending August 26, and deaths increased by nearly 18% from the prior week, the September 7 New York Times reports. This marks the seventh consecutive week of increases. The Omicron…

Read More

Editor's Note The Centers for Disease Control and Prevention, on August 24, announced the launch of a new program to strengthen survival and recovery rates for sepsis patients, called the “Hospital Sepsis Program Core Elements.” The program is aimed at helping hospitals implement, monitor, and optimize sepsis programs and improve…

Read More

Editor's Note The COVID-19 Omicron subvariant EG.5 is now the dominant variant in the US, replacing Arcturus XBB.1.16, according to the August 4 US News & World Report. EG.5 accounts for more than 17% of new COVID-19 cases in the US in the past 2 weeks, and it is increasing…

Read More

Editor's Note This study, led by nurse researchers at the College of Nursing, University of Wisconsin-Milwaukee, explores the experiences of infection preventionists (IPs) during the COVID-19 pandemic. Responses from 61 IPs surveyed were included in the analysis. Among the findings: The initial phases of COVID-19 was a time of clinical…

Read More

Editor's Note Centers for Disease Control and Prevention (CDC) data is showing an uptick in COVID-19 positivity rates and emergency department visits after months of decline, according to the July 24 US News and World Report. Cases of the Omicron subvariant EG.5, which was recently added to the World Health…

Read More

Editor's Note The Centers for Disease Control and Prevention (CDC), on May 26, released an update on the spread of COVID-19 at its 2023 Epidemic Intelligence Service (EIS) Conference in Atlanta in April. The conference was attended by some 1,800 in-person attendees. A rapid assessment team was gathered to survey…

Read More

Editor's Note Estimates from the Centers for Disease Control and Prevention find the emerging COVID-19 Omicron subvariant XBB.1.16, dubbed Arcturus, is responsible for more than 14% of COVID-19 cases in the US over the past 2 weeks, up from nearly 7% in the prior 2 weeks, according to the May…

Read More

Editor's Note The Centers for Disease Control and Prevention (CDC) estimates that the Omicron subvariant XBB.1.16, also referred to as Arcturus, accounted for nearly 12% of COVID-19 cases in the US last week, and another relative, XBB.1.9.1 is responsible for 9% of cases, as of April 29, the April 28…

Read More